Clinical Trial

Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2024 (before its estimated February 5, 2025 completion). Its status may not reflect the trial's current state.
Summary
A prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System manufactured by EndoNom Medtech (Hangzhou) Co., Ltd. for true/false aortic arch aneurysms and ulcers involving aortic arch . (GIANT Study)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-02-19; most recent amendment 2024-04-28.
Status change: Recruiting → Active, Not Recruiting 2024-04-28
Trial Details
NCT Number NCT04765592
Lead Sponsor Hangzhou Endonom Medtech Co., Ltd.
Conditions Aortic Arch Aneurysm
Enrollment 88 participants
Start Date 2021-06-07
Primary Completion 2025-02-05 (estimated)
Study Completion 2029-02-05 (estimated)
Updated on ClinicalTrials.gov 2024-04-30